Dong-A to conduct phase I trial for new treatment of premature ejaculation

Published: 2010-05-10 06:56:00
Updated: 2010-05-10 06:56:00
Dong-A Pharmaceutical Co. said on May 4 it will conduct its Phase I trial for a new medicine (codename: DA-8031) for the treatment of premature ejaculation (PE).

The company said the study will be conducted in Seoul National University Hospital.

DA-8031 is shown to be effective in animal st...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.